I have mapped eight major effect QTLs that modulate neuron number in
mice. These QTLs are the first loci known to control normal variation in
cell number in the vertebrate CNS. Identifying the specific genes that these
QTLs reside in awaits candidate gene analysis. However, even if the QTLs are
not cloned in the near future, once the mouse and human genome is completely
sequenced, the identification of QTLs mapped in mouse will help to assign
the function of genes. Today, with the advent of expressed site sequence tag
mapping, genes are being mapped at a breakneck speed. Thus, the bottleneck
now is identifying gene function and QTL mapping will certainly aid in this
task.
In chapter 5, I mapped a QTL, Nnc1, that is responsible for more
than half of the genetic variance in ganglion cell number in mice and
generates the pronounced bimodality found among strain averages (see Chapter
5, (Williams et al., 1998). Thyroid hormone receptor alpha is a
superb candidate gene for Nnc1 and the reduced ganglion cell number
in the Thra null mice provides further support for Thra’s
influence on ganglion cell number. Further support for Thra can be
acquired by first identifying the genetic variant at the Thra locus
and determining whether the variant is associated with variation in ganglion
cell number in other strains.
The genetic variants can be found by sequencing the gene from the high
and low strains. Sequencing has become so efficient that entire intervals
have been sequenced to identify a genetic mutation (Yu et al., 1996).
Another way to locate the genetic variants is to run short segments of the
gene on a neutral 5% polyacrylamide gel and look for shifts in the band
migration between the DNA from high and low strains. This technique is
called single strand conformation polymorphism (SSCP) and can detect even a
single point mutation (Orita et al., 1988).
A candidate gene must be proved definitively. Proof for a candidate gene
can be obtained if the quantitative phenotype changes in a transgenic animal
expressing the allelic variant. In the same concept, gene candidates can
also be tested by transferring the QTL interval onto another background
strain with the generation of a congenic mouse strain (Smithies and Maeda,
1995). For polygenic traits, such as epilepsy, congenics have been used to
refine the location of putative QTLs and measure QTL effects (Frankel,
1995).
Nature of the QTL
Substantial trait variation within a population in the wild result from
the absence of selective pressures and indicates that the trait is not
important for survival. However, the magnitude of the variation in brain
weight and ganglion cell among inbred strains is probably not representative
of the wild populations from which they were derived. During the inbreeding
process inbred strains may have encountered new selection pressures that
could have resulted in a non-random selection of alleles. Thus, the allele
frequency among inbred strains may not represent the wild populations from
which they were derived. Surprisingly, the genetic divergence found among
the inbred strains averages 40%, which is larger than that expected from
mixing the progenitor subspecies (Crusio, 1992). The wide divergence between
strains could result from a selection of heterozygosity during the early
generations of inbreeding and then the subsequent fixation of one allele
(Fitch and Atchley, 1985). Alternatively, the large genetic variation among
mice could result from the absence of selective pressures in the sustained
life of the laboratory mouse, allowing over generations the accumulation of
mutations that would be deleterious in the wild. However, it is worth
emphasizing that an extensive variety of mice were sampled from a wide range
of ages, both sexes, and taken from different litters and different mothers
within strains. The environmental range that we have sampled is appreciable
and is typical of most research colonies, perhaps even stable wild
populations. Nevertheless, the specificity of the genetic variation should
still be representative and the increased genetic diversity between inbred
strains of mice is advantageous for the detection of quantitative trait loci
with small effects.
The human brain size is roughly twice as big as that of a chimpanzee’s
yet their genetic code differs by only 1.6%. How is it that this small
genetic difference can account for the substantial morphological differences
found between chimpanzees and humans? It is possible if the genetic
variation effects the expression parameters of key genes during development,
such as growth hormones, which have widespread growth effects (Slack and
Ruvkun, 1997). Genetic variation within key genes could produce effects by
changing their level or timing of gene expression. For example, a higher
level of IGF-I expressed under the control of the metallothionine promoter
in transgenic mice results in brains weighing 50% more and containing 21%
more DNA compared to normal mice (D'ercole, 1993). Differences in the timing
of gene expression can affect the timing of developmental events resulting
in heterochronic differences between species. An example of heterochrony is
the difference in duration of brain growth between chimpanzees and humans.
Brain growth ceases at birth in chimpanzees, but continues to grow for
another two years after birth in humans (Raff, 1996). Evidence that
heterochrony exists in developing brain processes between species of Mus
was found from like-genotype cells clustering in the brains of interspecies
chimeric mice when they are typically intermixed within intraspecies
chimeras (Goldowitz, 1989). There is no doubt that heterochrony plays a
significant role in the generation of evolutionary differences.
Genetic variation has been found in two key regulatory genes that
function in the somatropic growth axis. Size variants of growth hormone
and insulin growth factor 2, are found to segregate in large and
small body sized mice (Elliott et al., 1990; Winkelman and Hodgetts, 1992).
How the genetic variants produce differences in body size are not known.
Alternatively, some genes may function only to create quantitative variation
by tweaking the efficacy of key genes. Many genes are redundant, since
knocking out some genes result in no obvious phenotype. This genetic
redundancy could serve to maintain quantitative variation in the species. A
species with an abundance of quantitative variation would be better equipped
to adapt through natural selection in the presence of environmental
pressure. However, it remains to be shown whether these "disposable" genes
actually contribute to genetic variation.
Recently, much progress has been made characterizing the molecular basis
of natural variation in bristle number in Drosophila (Long, 1995).
Five QTLs that associate with variation in bristle number have been mapped
to Chr 3. Genes that map nearby and are known to be involved in bristle
formation were selected as candidate genes. One of the candidate genes is
Delta. Delta is a transmembrane protein involved in the lateral
inhibition process of bristle formation. Delta serves as the ligand for
Notch and can activate the Notch pathway and suppress the neurogenic fate. A
lower level of Delta expression in a cell would down regulate Notch leading
to a neurogenic cell fate such as the bristle, an external sensory organ of
the peripheral nervous system. Two sites that associate with variation in
abdominal and sternopleural bristle number have been identified in the
introns of the candidate gene Delta. How the sequence variants
in Delta’s introns change Delta’s function and modify bristle
formation is not yet known. However, if the two sites in Delta are
located within enhancer sequences, which are known to reside within introns,
the expression level of Delta could be altered. The two genetic variants in
Delta are individually responsible for 12% and 6% of the total
genetic variation in bristle number on Chr 3. This large effect size
demonstrates that natural quantitative variation in vertebrates can result
from a small number of loci with large effects.
Macromutations in genes that affect neuron number can provide insight
into the genetic control of neuron number. For example, in Drosophila
a mutation called gene minibrain (mnb) results in a marked reduction
in the optic lobes and central brain hemispheres. The mnb gene
encodes a cell type-specific serine-threonine protein kinase involved in the
regulation of cell division (Tejedor et al., 1995). The mouse and human
homologs of mnb have been mapped to Chr 16 and 21, respectively
(Shindoh et al., 1996). Transgenic mice carrying extra dosages of the gene
mnb have learning deficits, implicating mnb as the critical
gene that leads to the learning problems and smaller brain size
characteristic of trisomy 21, or Down syndrome (Smith et al., 1997). Thus,
the critical role mnb plays in cortical neurogenesis is conserved
from Drosophila to humans. A mouse mutation called megencephly causes
hypertrophy of the brain resulting in a 25% larger brain size (Donahue et
al., 1996). This mutation was mapped to mid-distal Chr 6 in the mouse. It is
not known how the megencephly mutation increases cell number or whether a
human homolog is responsible for megencephaly-related syndromes in humans,
e.g., Sotos syndrome, Robinow syndrome, Canavan's disease, and Alexander
disease. Natural allelic variants in genes such as mnb and
megencephaly could produce natural variation in brain weight.
The work presented here on the natural variation of neuron number in mice
has provided a glimpse into the genetic bases of variation in neuron number.
Our understanding of the genetic bases of natural variation in CNS structure
both within and between species is still in its infancy.In light of the
recent advances in mapping tools and genomic databases, the future holds
much promise for rapid advances in our knowledge of the genetic bases of
natural variation in the brain.
Return to Table of Contents